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on the postoperative course. In particular, the follow-up
period in group S patients was relatively short inasmuch as
they were growing; therefore, the inference regarding free-
dom from conduit obstruction and the need for reoperation
in relation to outgrowth is uncertain. Further, a long-term fol-
low-up study is essential.
In conclusion, we evaluated the technical feasibility of
ECFP in patients weighing less than 10 kg. In terms of mor-
tality and midterm results, the outcome of ECFP was accept-
able in patients who weighed less than 10 kg. Currently, it
may not be possible to consider ECFP as the standard proce-
dure in patients weighing less than 10 kg. However, the pro-
cedure may be feasible in patients who, for instance, have
severe cyanosis owing to pulmonary arteriovenous malfor-
mation. Further studies are required to assess the late hemo-
dynamics of patients with small conduits when they achieve
full somatic growth and the long-term outcome of these small
conduits.
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DDiscussion
Dr Ed Petrossian (Madera, Calif). Dr Ikai, I enjoyed your presen-
tation. I will make a comment on the paper inasmuch as I believe it is
an important subject, and I have 3 questions for you. The comment
will be primarily focused on the issue of putting in small conduits in
small patients.
In this study, you and your colleagues have shown that the ECFP
can be performed with excellent perioperative and midterm out-
comes in patients less than 2 years of age and less than 10 kg in
weight. At a median follow-up time of 29 months, there were no
thromboembolic events and none of the patients required conduit re-
placement owing to obstruction. I believe this is an important and
timely paper because it brings into light the concerns and controver-
sies about the timing of this operation with respect to age, weight,
and the related issue of conduit size. Regarding the choice of conduit
size, this decision is influenced by two competing factors. The first is
the desire to insert a large conduit to avoid growth-related obstruc-
tion. Ideally, the conduit should match or slightly exceed the size of
an average adult IVC at the level of the diaphragm. The second is the
desire to avoid extremes of IVC–conduit mismatch. Significant mis-
match can lead to turbulence, energy loss, stasis, and thrombosis. In-
formation on the average size of the adult IVC at the level of the
diaphragm is limited. Most studies instead report the size of the in-
frahepatic or most commonly the infrarenal IVC. Accuracy of the
studies is affected by the fact that the IVC is an extremely compliant
vessel so that its diameter and shape vary greatly with a number of
factors, including patient body position, volume status, systemic ve-
nous pressure, phase of respiration, and to a lesser extent phase of
the cardiac cycle. In adults, the size of the IVC does not correlate
with age, height, weight, or body surface area. Therefore, prediction
of a patient’s future IVC diameter based on projections of the pa-
tient’s future height, weight, or body surface area as an adult may
be inaccurate.
The most consistent finding of the IVC diameter is that it corre-
lates well with right-sided systemic venous pressures. Patients with
elevated pressures have been shown to have significantly dilated
IVCs. It therefore follows that an adult patient with a Fontan circu-
lation and an inherently elevated systemic venous pressure will be
expected to have a dilated IVC. The available data on IVC diameteracic and Cardiovascular Surgery c Volume 135, Number 5 1151
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Dbased on angiography, computed tomographic scan, and echocar-
diographic studies suggest that the average normal IVC diameter
ranges from 20 to 28 mm with significant interstudy variability. In
patients with elevated systemic venous pressures, the average diam-
eter is about 30 mm. These data suggest that most conduits, espe-
cially those less than 18 or 20 mm, eventually will need to be
replaced. It appears, therefore, that a protocol of using small con-
duits in patients less than 10 kg in weight will likely lead to signif-
icant conduit obstruction and the need for early reoperation. One
option, of course, is to routinely use 20-mm conduits in these small
patients. Although you did not report any case of thromboembolism,
we believe that insertion of markedly oversized conduits is not an
optimal solution either, inasmuch as it can cause significant IVC–
conduit size mismatch and related complications.
I have 3 questions for you. First, what size mismatch between the
IVC and the conduit are you comfortable with at the time of the op-
eration? In other words, when you are trying to decide what size con-
duit to insert at the time of the operation, how much larger can the
conduit be compared with the size of the IVC?
Dr Ikai. Thank you, Dr Petrossian, for your comments and the
question. Size mismatch between the IVC and the conduit may
not be so big an issue. We have not measured the size of the IVC
during the operation because we can cut the IVC not on the IVC it-
self. Maybe sometimes we can make the incision line to the right
atrium and maybe the IVC tissue has included some right atrial tis-
sue. That means that these tissues are very flexible and sometimes
we can put a much larger conduit on that. Maybe a problem has hap-
pened with size mismatch between the pulmonary artery to the con-
duit. Another big issue is if we insert too large a conduit, pulmonary
vein obstruction may result. We think that in a baby weighing less
than 10 kg, an18 mm in diameter conduit is suitable. In a baby
less than 20 kg, maybe a 20 mm in diameter conduit is suitable.
Dr Petrossian. I agree with you. We also use a cuff of atrium to
anastomose to the conduit and not the IVC itself so that we can put in
a larger conduit, and the conduit is almost always larger than the
IVC; however, there is a limit to that. In our experience, and I think
this is corroborated by others, we try to avoid upsizing the conduit
by more than 25% compared with the size of the IVC to avoid a sud-
den change in vessel caliber going from the IVC to the conduit. This
discrepancy has been demonstrated to cause a lot of turbulence,
energy loss, stasis, and thrombosis.
My second question is, since your patients less than 10 kg are at
risk for outgrowing their conduits, how do you plan on monitoring
them? In other words, what diagnostic modalities do you use to look
for conduit obstruction as these patients grow?
Dr Ikai. I showed the postoperative angiogram in the presenta-
tion. We routinely perform angiography a year after the operation.
At that time, if the conduit shows some obstruction, it may be a prob-
lem, but so far we have not seen any obstruction on the angiogram. If
the patient needs more follow-up, we use a computed tomographic
angiogram or a magnetic resonance angiogram because they are less
invasive measures.
Dr Petrossian. In our experience with more than 360 Fontan pa-
tients, we have been primarily monitoring them with echocardio-
grams, but I agree with you that as these patients grow and
become more at risk for conduit obstruction, more accurate imaging
modalities are going to be necessary. Magnetic resonance imaging,1152 The Journal of Thoracic and Cardiovascular Surgery c Mcomputed tomography, and probably also cardiac catheterization
may be needed to measure the gradient across these conduits.
My third and last question is, what will be your criteria for
reoperation for conduit obstruction in asymptomatic patients?
We all agree that symptomatic patients will need conduit replace-
ment, but at what point and with what diagnostic findings will
you be comfortable with replacing a conduit in an asymptomatic
patient?
Dr Ikai. It is very difficult to change the conduit in an asymp-
tomatic patient. However, if there is a pressure gradient between
the IVC and the conduit at catheterization, we may have to do the
operation. During catheterization, with the patient in the resting po-
sition, the data, the pressure number, may not be accurate, so we
probably will have to do an exercise test for these patients and get
some exercise tolerance. If these numbers become low, that may
indicate that the conduit should be changed.
Dr Petrossian. I agree that exercise testing may be one way to
determine when it is time for conduit replacement. Imaging modal-
ities may not be sufficient. These IVCs will eventually dilate be-
cause they are very compliant vessels. The fact that they become
very large does not necessarily mean that they are obstructed. In ad-
dition, collaterals will develop, just as with the SVC, in patients with
bidirectional Glenn shunts, so it will be difficult to figure out when it
is time to replace the conduit. However, I think if at cardiac cathe-
terization there is any gradient, even a small amount of gradient
between the conduit and a dilated IVC in combination with an
abnormal exercise test, then it will be time to proceed with conduit
replacement even if the patient is asymptomatic.
Dr Ikai. In terms of reoperation, when we started this strategy,
we were still thinking about this Fontan procedure as a palliative
procedure because we did not have any long-term result with this
small conduit. Now, because of the good result of the Fontan con-
version from the classic Fontan to the total cavopulmonary connec-
tion, we think the operation itself is not so risky, especially in
a patient who has an established Fontan circulation.
Dr Petrossian. I certainly I agree with that. When the patients
return to have the conduit replaced, it is not as big an operation or
as risky as the first primary Fontan.
Dr Winfield Wells (Los Angeles, Calif). My question is pretty
simple. Why do this? What are the advantages? Your 2 groups
came out the same. The saturations are the same in the longer-
term follow-up. They seemed to have the same saturations when
you did them, so why not wait? What are the advantages of doing
this operation in a patient weighing less than 10 kg?
Dr Ikai.We believe that the final goal of the Fontan operation is
elimination of cyanosis, and in these 2 groups the big difference is
not only the body weight but also the age. We did this operation
at around a year of age. If we wait until patients become 15 kg,
we may have to wait until the baby becomes 2 or 3 years old. Wait-
ing these 1 or 2 years may not be good for the patient. In these 2
years the patient’s activity is increasing. Maybe the child starts
walking and running. This quality we think is very important. We
want to eliminate cyanosis. That is our reason to do this operation.
Dr Wells. Do you have any evidence for that?
Dr Ikai. We have not published yet, but when we do this oper-
ation at the younger age, some children catch up soon. This is
another reason to do this operation early.ay 2008
